数字乳腺X线摄影立体定位活检与数字乳腺断层摄影引导活检的比较:活检目标、病理结果及不一致率的差异
该研究回顾性比较了数字乳腺X线摄影(DM)立体定位活检与数字乳腺断层摄影(DBT)引导活检在活检目标类型、病理结果及影像-病理不一致率上的差异。结果显示DBT引导活检中结构扭曲目标比例更高(17.7% vs 2.0%),放射状硬化性病变检出更多(8.3% vs 1.7%),不一致率更高(4.5% vs 1.4%),但恶性肿瘤总体比例相似(24.8% vs 27.8%)。
要点
- DBT引导活检中结构扭曲为目标的活检比例显著高于DM引导活检(17.7% vs 2.0%)。
- DBT引导活检检出放射状硬化性病变的比例高于DM引导活检(8.3% vs 1.7%)。
- DBT引导活检的影像-病理不一致率高于DM引导活检(4.5% vs 1.4%),不一致病例中多数为结构扭曲。
关键影像表现/征象
- 钙化是两组最常见的活检目标,DM引导活检中占89.9%(578/643),DBT引导活检中占71.1%(542/762)(P = .03)。
- 结构扭曲活检率在DM引导活检中为2.0%(13/643),在DBT引导活检中为17.7%(135/762)(P = .01)。
诊断标准与关键数值
- 总体恶性肿瘤率在DM引导活检为27.8%(179/643),在DBT引导活检为24.8%(191/762)(P = .54)。
- 浸润性恶性肿瘤占恶性肿瘤的比例在DBT引导活检为37.4%(72/191),在DM引导活检为29.0%(52/179)(P = .35)。
- 放射状硬化性病变检出率在DBT引导活检为8.3%(95%CI:6.0, 10.0),在DM引导活检为1.7%(95%CI:1.0, 3.1)(P = .01)。
- 影像-病理不一致率在DM引导活检为1.4%(95%CI:1.0, 2.7),在DBT引导活检为4.5%(95%CI:3.2, 6.3)(P = .01)。
临床应用与阅片要点
- DBT引导活检时需注意结构扭曲目标比例较高,报告时应描述结构扭曲的影像特征。
- DBT引导活检后影像-病理不一致率较高(4.5%),且不一致病例中多数为结构扭曲(34例中30例),阅片时需关注结构扭曲的病理符合性。
- DBT引导活检可检出更多放射状硬化性病变,报告时应考虑该病变可能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Digital breast tomosynthesis (DBT)-guided biopsy is increasingly used in practice. It is important to know expected changes in biopsy targets, pathologic results, and discordance rates. Purpose To compare biopsy target types, pathologic results, and discordance rates for 2 years preceding and 2 years following implementation of DBT-guided biopsy. Materials and Methods All 9-gauge vacuum-assisted core biopsies from a single tertiary breast center that used digital mammography (DM) stereotactic guidance from 2013 to 2015 and DBT-guided biopsy from 2015 to 2017 were retrospectively reviewed. All mammographic examinations were performed with DBT. Patient demographics, biopsy target type, pathologic reports, surgical excision specimens when available, breast density, and imaging follow-up results were recorded. Biopsy targets and discordance rates between radiologic and pathologic examinations were compared between the two biopsy groups. Generalized mixed modeling was used to examine results before and after DBT-guided biopsy. Results A total of 1313 women underwent 1405 breast biopsies: 643 by using DM (August 2013 to July 2015) (median age, 56 years; interquartile range, 49-66 years) and 762 by using DBT (August 2015 to July 2017) (median age, 58 years; interquartile range, 50-67 years), (P = .58). Calcifications were the most common biopsy target for both groups, constituting 89.9% (578 of 643) of DM-guided biopsies and 71.1% (542 of 762) of DBT-guided biopsies (P = .03). The rate of architectural distortion biopsies was 2.0% (13 of 643) with DM-guided biopsy and 17.7% (135 of 762) with DBT-guided biopsy (P = .01). Although overall malignancy rate was similar for DM-guided biopsy (27.8% [179 of 643]) and DBT-guided biopsy (24.8% [191 of 762], P = .54), DBT-guided biopsy helped identify a similar percentage of invasive malignancies (37.4% [72 of 191] vs 29.0% [52 of 179] at DM P = .35), but more radial sclerosing lesions (8.3% [95% confidence interval {CI}: 6.0, 10.0] vs 1.7% [95% CI: 1.0, 3.1]) (P = .01). The discordance rate was 1.4% (95% CI: 1.0, 2.7) with DM-guided biopsy and 4.5% (95% CI: 3.2, 6.3) with DBT-guided biopsy (P = .01). Of the 34 discordant DBT-guided biopsies, 30 were architectural distortions. Conclusion With the transition to digital breast tomosynthesis-guided biopsy, more architectural distortions were biopsied, more radial sclerosing lesions were identified, and more discordance existed in radiologic and pathologic examinations, with a similar percentage of carcinomas diagnosed. © RSNA, 2020 Online supplemental material is available for this article.
引用
- Rochat CJ, Baird GL, Lourenco AP, et al. Digital Mammography Stereotactic Biopsy versus Digital Breast Tomosynthesis-guided Biopsy: Differences in Biopsy Targets, Pathologic Results, and Discordance Rates. Radiology. 2020. PMID: 31961261. doi:10.1148/radiol.2019191525
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。